The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

J.R.M. Ellis , P.J. Keating , J. Baird , E. F. Hounsell , D. V. Renouf , M. Rowe , D. Hopkins , M.F. Duggan-Keen , J.S. Bartholomew , L.S. Young & P.L. Stern

To read this article in full you may need to log in, make a payment or gain access through a site license (see right).